(ix) Contingent liabilities and provisions

a) Provisions

Provisions are recognised when the Company has a legal / constructive obligation as a result of a past event, for which it is probable that a cash outflow may be
required and a reliable estimate can be made of the amount of the obligation.

When a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the
effect of the time value of money is material).

b) Contigencies

Contingent liabilities are disclosed after evaluation of the facts and legal aspects of the matter involved, in line with the provisions of Ind AS 37.

The company records a liability for any claims where a potential loss probable and capable of being estimated and discloses such matters in its financial statements, if
material. For potential losses that are considered possible, but not probable, the Company provides disclosures in the financial statements but does not record a
liability in its financial statements unless the loss becomes probable.

Contingent assets are not recognised in the books of the accounts but are disclosed in the notes. However, when the realisation of income is virtually certain, then the
related asset is no longer a contingent asset, but it is recognised as an asset and the corresponding income is booked in the Statement of Profit and Loss.

(x) Income taxes

The income tax expense or credit for the period is the tax payable on the current period’s taxable income based on the applicable income tax rate adjusted by changes
in deferred tax assets and liabilities attributable to temporary differences and to unused tax losses.

Deferred income tax is provided in full, using the liability method on temporary differences arising between the tax bases of assets and liabilities and their carrying
amount in the financial statement. Deferred income tax is determined using tax rates (and laws) that have been enacted or substantially enacted by the end of the
reporting period and are excepted to apply when the related deferred income tax assets is realised or the deferred income tax liability is settled.

Deferred tax assets are recognised for all deductible temporary differences and unused tax losses, only if, it is probable that future taxable amounts will be available
to utilise those temporary differences and losses.

Deferred tax assets and liabilities are offset when there is a legally enforceable right to offset current tax assets and liabilities and when the deferred tax balances
relate to the same taxation authority. Current tax assets and tax liabilities are off set where the Company has a legally forceable right to offset and intends either to
settle on a net basis, or to realize the asset and settle the liability simultaneously.

Current and deferred tax is recognised in the Statement of Profit and Loss, except to the extent that it relates to items recognised in other comprehensive income or
directly in equity. In this case, the tax is also recognised in other comprehensive income or directly in equity, respectively.

(xi) Cash and Cash Equivalents

Cash and cash equivalents include cash in hand and at bank, deposits held at call with banks.For the purpose of the Statement of Cash Flows, cash and cash
equivalents consists of cash and short term deposits, having maturity less than 12 months.

(xii) Financial Instruments

A. Initial recognition

Financial assets and financial liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issue of financial
assets and financial liabilities (other than financial assets and financial liabilities at fair value through profit or loss) are added to or deducted from the fair value of
financial asset or financial liabilities, as appropriate, on initial recognition.

B. Subsequent measurement

(i) Financial assets carried at amortised cost : A financial asset is subsequently measured at amortised cost if it is held in order to collect contractual cash flows
and the contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount
outstanding.

(ii) Financial assets carried at fair value through other comprehensive income (FVTOCI): A financial asset is subsequently measured at FVTOCI if it is held not
only for collection of cash flows arising from payments of principal and interest but also from the sale of such assets. Such assets are subsequently measured at fair
value, with unrealised gains and losses arising from changes in the fair value being recognised in other comprehensive income.

(iii) Financial assets carried at fair value through profit or loss (FVTPL): A financial asset which is not classified in any of the above categories are subsequently
measured at fair value through profit or loss.

(iv) Financial liabilities : Financial liabilities are subsequently measured at amortized cost using the effective interest method. For trade and other payables
maturing within one year from the Balance Sheet date, the carrying amounts approximate fair value due to the short maturity of these instruments.

De-recognition of financial Asset

A financial asset is primarily derecognised (i.e. removed from the balance sheet) when:

• The rights to receive cash flows from the asset have expired, or

• The Company has transferred its rights to receive cash flows from the asset or has assumed an obligation to pay the received cash flows in full without material
delay to a third party under a ‘pass-through’ arrangement; and either (a) the Company has transferred substantially all the risks and rewards of the asset, or (b) the
Company has neither transferred nor retained substantially all the risks and rewards of the asset, but has transferred control of the asset. When the Company has
transferred its rights to receive cash flows from an asset or has entered into a pass-through arrangement, it evaluates if and to what extent it has retained the risks
and rewards of ownership.

De-recognition of financial liability

A financial liability is derecognised when the obligation under the liability is discharged or cancelled or expires. The difference between the carrying amount of a
financial liability that has been extinguished or transferred to another party and the consideration paid is recognised in profit or loss as "Other Income" or "Finance
Expense".

Offsetting of financial instruments

Financial assets and financial liabilities are offset and the net amount is reported in the balance sheet if there is a currently enforceable legal right to offset the
recognised amounts and there is an intention to settle on a net basis, to realise the assets and settle the liabilities simultaneously.

C. Impairment

(i) . Financial assets

The Company recognizes loss allowances using the expected credit loss for the financial assets which are not measured at fair value through profit or loss.

The Company do not recognise expected credit loss on Trade receivables.

Individual trade receivables are written off when management deems them not to be collectible.

(ii) . Non - financial assets
Tangible and intangible assets

Property, plant and equipment and intangible assets are evaluated for recoverability whenever there is any indication that their carrying amounts may not be
recoverable. An impairment loss is recognised for the amount by which the asset’s carrying amount exceeds its recoverable amount. The recoverable amount is the
higher of an asset’s fair value less costs of disposal and value in use. For the purpose of assessing impairment, assets are grouped at the lowest levels for which there
are separately identifiable cash inflows which are largely independent of the cash inflows from other assets or group of assets (cash-generating units). The Company
review/assess at each reporting date if there is any indication that an asset may be impaired.

(xiii) Segment Reporting

Operating Segment are reported in a manner consistent with the Internal Reporting provided to the Chief Operating Decision Maker.

The Company is engaged providing Superspeciality and general hospital services which constitutes a single business segment, so there are no other Reportable
Segments.

(xiv) Operating Cycle

Based on the nature of products / activities of the Company and the normal time between acquisition of assets and their realisation in cash or cash equivalents, the
Company determined its operating cycle as 12 months for the purpose of classification of its assets and liabilities as current and non-current.

(xv) Investments in Equity Instruments

Investments in Equity Instruments have been valued at their fair values through Profit and Loss, as on the closing date. The fair value has been valued as per the
intrinsic value of shares of the company in which our company has invested.

Note 1.5 - Critical Accounting Assumptions

The estimates and judgements used in the preparation of the financial statements are continuously evaluated by the Company and are based on historical experience
and various other assumptions and factors (including expectation of future events) that the Company believes to be reasonable under the existing circumstances.
Differences between actual results and estimates are recognised in the period in which the results are known/materialised.

The said estimates are based on the facts and events that existed as at the reporting date, or that which occured after the date but provide additional evidence about
the conditions existing at the reporting date.

a) Property, plant and equipment

Management assesses the remaining useful lives and residual value of property, plant and equipment. Management believes that the assigned useful lives and
residual value are reasonable.

b) Income taxes

Management judgment is required for the calculation of provision for income taxes and deferred tax assets and liabilities.

The Company reviews at each balance sheet date the carrying amount of deferred tax assets and liabilities. The factors used in estimates may differ from actual
outcome which could lead to significant adjustment to the amounts reported in the standalone financial statements.

c) Contingencies

Management judgement is required for estimating the possible outflow of resources, if any, in respect of contingencies/claim/litigations against the Company as it is
not possible to predict the outcome of pending matters with accuracy.

d) Impairment of accounts receivable and advances

Trade receivables carry interest and are stated at their fair value as reduced by appropriate allowances for expected credit losses. Individual trade receivables are
written off when management deems them not to be collectible. Impairment is recognised for the expected credit losses.

e) Discounting of Security deposit, and other long term liabilities

For majority of the security deposits received, the timing of outflow, as mentioned in the underlying contracts, is not substantially long enough to discount. The
treatment would not provide any meaningful information and would have no material impact on the financial statements.

Financial Instrument by category and hierarchy

The fair values of the financial assets and liabilities are included at the amount at which the instrument could be exchanged in a current transaction
between willing parties, other than in a forced or liquidation sale.

The following methods and assumptions were used to estimate the fair values:

1. Fair value of cash and short-term deposits, trade and other short term receivables, trade payables, other current liabilities, short term loans from
banks and other financial institutions approximate their carrying amounts largely due to short term maturities of these instruments.

2. Financial instruments with fixed and variable interest rates are evaluated by the Company based on parameters such as interest rates and
individual credit worthiness of the counterparty. Based on this evaluation, allowances are taken to account for expected losses of these receivables.
Accordingly, fair value of such instruments is not materially different from their carrying amounts.

3. IND AS 101 allows Company to fair value its property, plant and machinery on transition to IND AS, the Company has fair valued property, plant
and equipment, and the fair valuation is based on deemed cost approach where the existing carrying amounts are treated as fair values.

4. The Transaction cost on the borrwings are amortised over the tenure of loan and fair values are arrived accordingly.

5. For other financial assets and liabilities that are measured at amortised cost, the carrying amounts are equal to the fair values.

The Company uses the following hierarchy for determining and disclosing the fair value of financial instruments by valuation technique:

Level 1: Quoted prices / published NVA (unadjusted) in active markets for identical assets or liabilities. It includes fair value of financial instruments
traded in active markets and are based on quoted market prices at the balance sheet date and financial instruments like mutual funds for which net
assets value (NAV) is published mutual fund operators at the balance sheet date.

Level 2: Inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly (that is, as prices) or
indirectly (that is, derived from prices). It includes fair value of the financial instruments that are not traded in an active market (for example, over-the-
counter derivatives) is determined by using valuation techniques. These valuation techniques maximise the use of observable market data where it is
available and rely as little as possible on the company specific estimates. If all significant inputs required to fair value an instrument are observable
then instrument is included in level 2.

Level 3: Inputs for the asset or liability that are not based on observable market data (that is, unobservable inputs). If one or more of the significant
inputs is not based on observable market data, the instrument is included in level 3.

FINANCIAL RISK MANAGEMENT
Financial risk factors

The Company’s principal financial liabilities comprise of trade payables, borrowings and other liabilities. The
main purpose of these financial liabilities is to manage finances for the Company’s operations and also for
purchase of capital assets and for safeguarding its interests under contracts.

The Company has given loans to its employees, trade and other receivables, investments in equity shares and
cash and cash equivalents that arise directly from its operations as a part of its financial assets.

The Company’s activities expose it to a variety of financial risks:

a. Market risk

Market risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of
changes in market prices.

Financial Instruments affected by Market Price Risk include investments made in equity instruments by the
Company.

There are no currency rate risk on the Company since all the transactions are done in the functional currency
(INR)

b. Credit risk

Credit risk is the risk that a counter party will not meet its obligations under a financial instrument or customer
contract, leading to a financial loss.

The company is engaged in providing medical services under which major amount is recieved in advanced from
patients and settled at the time of payment of billing amount. In case of insured patients amount is recieved
through TPA and government agencies which is subject to slight credit risk . Financial Instruments like trade
receivables and loans forwarded to employees are subject to slight credit risk against which the Company has
booked Expected Credit Losses.

c. Liquidity risk

Liquidity risk is the risk that the Company may not be able to meet its present and future cash and
collateral obligations without incurring unacceptable losses.

Being a cash rich company, it does not have any acute liquidity risk and has no lines of credit in
the forms of loans payable.

Market Risk

Commodity price risk and sensitivity

Being a Professional Company, engaged in medical sector the risk of the Company is bare minimum.

Credit risk

Credit risk refers to the risk that a counter party will default on its contractual obligations resulting in financial
loss to the Company. The Company takes due care while extending any credit as per the approval matrix
approved by Board of Directors.Company have Rs. 10955644.10 as trade recievables outstanding for more than
36 months , as per Board of Directors, company is not required to book any expected credit losses.

Details and terms and conditions of borrowings are as under:

1. A)Vehicle loan from ICICI Bank is secured against hypothication of specified Vehicle, repayable in 60 Equited
monthly installment of Rs. 20,468/- each , bears rate of interest of 9.25%.

B) Equipment Loan for Medical Oxygen Plant from Yes Bank against hypothecation of the Medical Oxygen Plant
purchased from Kamtech. The loan is repayable in 60 equated monthly installments, including a 6-month
moratorium and 54 installments of ^70,879 each, at an interest rate of 7.50%.

C) Vehicle Loan from HDFC Bank is secured against hypothecation of the specified vehicle. The loan is repayable
in 84 equated monthly installments of ^28,332 each, at an interest rate of 8.50%.

D) Equipment Loan for Medical Equipment from IndusInd Bank Ltd. against hypothecation of proposed assets
purchased from Phoenix Medical Devices, Anupan Surgicals, and Sanma Medineers Vision Pvt. Ltd. The loan is
repayable in 48 equated monthly installments of 11,13,532 each, at an interest rate of 9.50%.

2. In the financial year 2020-21, an overdraft limit of Rs.700.00 Lakhs was sanctioned from AU Small Finance
Bank at an interest rate of 9.00% p.a., secured by way of hypothecation of all present and future current assets
of the company and the land & building situated at 38, Kanota Bagh, Jawahar Lal Nehru Marg, Jaipur, in the
name of Dr. Bimal Roy Soni, Managing Director of the company. The facility was also secured by the personal
guarantees of Dr. Bimal Roy Soni, Managing Director, and Dr. Anju Soni, Director of the company.

Out of the total limit of Rs.700.00 Lakhs, Rs.300.00 Lakhs was an overdraft limit, which was renewed yearly,
and the balance Rs.400.00 Lakhs was a drop-down limit for 120 months. This limit was to be reduced by
Rs.3,33,333.33 per month at the end of each month. Subsequently, the same was taken over by Kotak Mahindra
Bank by way of a Term Loan of Rs.400.00 Lakhs, repayable in 84 months, along with an overdraft limit of
Rs.300.00 Lakhs, which is renewed yearly.

Both the above loans from Kotak Mahindra Bank carried an interest rate of 6.80% (RPRR 4.00% p.a. plus spread
2.80% p.a.; at present, the RPRR is 5.40% p.a.).

At the February 2024, the above two loans were taken over by YES Bank, where Rs.500.00 Lakhs was Term Loan
repayable in 180 months at an interest rate of (EBLR spread 2.76%). The EMI is Rs.5,14,896/-. Additionally,
Rs.490.00 Lakhs was sanctioned as a DLOD facility, with an interest rate of (EBLR spread 2.76%). Interest is
calculated on the utilised limit, and the monthly drop-down repayment is Rs.2,72,223.

These facilities are secured by hypothecation of present and future current assets and movable fixed assets of
the company, along with an equitable mortgage of the land and building situated at 38, Kanota Bagh, Jawahar
Lal Nehru Marg, Jaipur, in the name of Dr. B. R. Soni, Managing Director of the company, and the personal
guarantees of Dr. B. R. Soni, Managing Director, and Dr. Anju Soni, Director of the company.

3. Bank Overdtat Limit of Rs. 90000/- taken from HDFC Bank Limited for collction account for Credit Cradt
Swap Machine of HDFC Bank against FDR of Rs.1.00 Lakhs, bears interet rate @ 1.50 % above the FDR interest
rate.

4. Insurance receivables financing facility taken from M/s SuperGrowth Investments Pvt Limited sanctioned limit
is 50 lakhs discounting period is 60 days,rate of interest is 12% interest is paid on utilisation of sanctioned limit
and is paid on discounting period basis. we also pay 88500 at the start of every quarter stating from 31st
january,2025.

29 CAPITAL RISK MANAGEMENT
Objective

The primary objective of the Company’s capital management is to maximize the shareholder value. i.e. to
provide maximum returns to the shareholders. The Company’s primary objective when managing capital is to
ensure that it maintains an efficient capital structure and healthy capital ratios and safeguard the Company’s
ability to continue as a going concern in order to support its business and provide maximum returns to the
shareholders. The Company also proposes to maintain an optimal capital structure to reduce the cost of
capital. No changes were made in the objectives, policies or processes during the year ended March 31, 2025
and March 31, 2024.

Policy

The Company manages its capital structure and makes adjustments in light of changes in economic
conditions and the rules and regulations framed by the Government under whose control the Company
operates.

Process

The Company manage its capital by maintaining sound/ optimal capital structure financial ratios, such as
net debt-to-equity ratio on a monthly basis and implements capital structure improvement plan when
necessary. Debt-to-equity ratio as of March 31, 2024, March 31, 2023 is as follows:

The fair values of above mention financial asset as on 31st March, 2025 for Fingrowth Bank is same as that of 31st march
2024, due to unavailability of information for the year 2024-25. In case Soni Hospital private Limited, the fair value of the
shares is same as that of 31st march 2024, due to unavailability of information for the year 2024-25.

Land has been taken at it's carrying value since the Fair Value of the land was not made available to us. Hence, there is no
IND AS adjustment in the Land While deriving the Intrinsic value of shares of Soni Hospitals Pvt Ltd.

37 Additional Regulatory Information Required by Schedule III of Companies Act, 2013

^I Details of Benami Property :

No proceedings have been initiated or are pending against the Company for holding any benami property under
the Benami Transactions (Prohibition) Act, 1988 (45 of 1988) and the rules made there under.

II Utilisation of Borrowed Funds and Share Premium:

(A) The Company has not advanced or loaned or invested funds (either borrowed funds or share premium or any other
sources or kind of funds) to any other person(s) or entity(ies), including foreign entities (intermediaries) with the understanding
(whether recorded in writing or otherwise) that the intermediary shall:

(a) Directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the
Company (ultimate beneficiaries) or

(b) Provide any guarantee, security or the like to or on behalf of the ultimate beneficiaries

(B) The Company has not received any funds from any person(s) or entity(ies), including foreign entities (funding party) with
the understanding (whether recorded in writing or otherwise) that the Company shall:

(a) Directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the funding party
(ultimate beneficiaries) or

(b) Provide any guarantee, security or the like to or on behalf of the ultimate beneficiaries.

III Compliance with Approved Scheme(s) of Arrangements:

No scheme of arrangement has been approved by the Competent Authority in terms of Sections 230 to 237 of the Companies
Act, 2013, hence, this is not applicable.

IV Undisclosed Income:

There are no transactions not recorded in the books of account that have been surrendered or disclosed as income during
the current or previous year in the tax assessments under the Income Tax Act, 1961.

V Details of Crypto Currency or Virtual Currency:

The Company has not traded or invested in crypto currency or virtual currency during the current or previous year.

^VI Valuation of Property, Plant and Equipment and Intangible Assets:

As the Company has chosen cost model for its Property, Plant and Equipment (Including Right-of-Use Assets) and Intangible
Assets, the question of revaluation does not arise

VII Loans or Advances to Specified Persons:

The Company has not granted any loans or advances in the nature of loans to promoters, directors, KMPs or the related
parties (as defined under Companies Act, 2013,) either severally or jointly with any other person.

_VIII Borrowings Secured Against Current Assets:

The Company had sanctioned borrowings limits as disclosed in Note 34. The returns/ statements of current assets filed by the
Company with the bank whenever bank required for the same.

IX Willful Defaulter:

The Company has not been declared Willful Defaulter by any bank or financial institution or government or any government authority.

X Registration of Charges or Satisfaction with Registrar of Companies:

The comapany has registered the charges when it takes loan from banks and financial instituted and satisfied its charged if repay the loan
wihin time period as prescribed by Companies Act, 2013. The company registers all the charges timely, when it takes loans from banks
and FIs and satisfies the charges when it repays the loan as per companies Act, 2013. However there are some charges which are yet to
be satisfied with ROC, of which the management has given the representation stating that the satisfaction is under process.

Compliance with Number of Layers of Companies:

The Company complies with the number of layers prescribed under clause (87) of Section 2 of the Act read with Companies
(Restriction on number of Layers) Rules, 2017.

Utilisation of Borrowings Availed from Banks and Financial Institutions:

The borrowings obtained by the Company have been utilised for the purpose for which the same was obtained.

38 The management has considered all the possible effects, if any, that may result from the pandemic relating to

COVID-19 on the results of operations, liquidity, capital resources and carrying amounts of trade receivables. In
developing the assumptions and estimates relating to the uncertainties as on the balance sheet date in relation to
the recoverable amounts of the assets, the management has considered the global economic conditions prevailing
as at the date of approval of these financial results and has used the internal and external sources of information
to the extent determined by it. The actual outcome of these assumptions and estimates may vary in future due to
the impact of the pandemic. The management will continue to monitor and assess the ongoing developments and
respond accordingly.

ON BEHALF OF BOARD OF DIRECTORS For Tambi Ashok & Associates

Chartered Accountants

Firm Registration No. : 005301C

DR. B.R.SONI (PRIYANKA GUPTA)

(MANAGING DIRECTOR) PARTNER

DIN : 00716246 Membership No. 432540

DR. ANJU SONI
(DIRECTOR)

DIN : 00716193

HARI KRISHAN TIWARI KRISHNA KUMAR SAINI

(COMPANY SECRETARY) (CHIEF FINANCIAL OFFICER)

JAIPUR

Dated: 30.05.2025